- Home
- CAC vs CRMD Comparison
CAC vs CRMD Comparison
Compare CAC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- CRMD
- Stock Information
- Founded
- CAC 1875
- CRMD 2006
- Country
- CAC United States
- CRMD United States
- Employees
- CAC N/A
- CRMD N/A
- Industry
- CAC Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- CRMD Health Care
- Exchange
- CAC Nasdaq
- CRMD Nasdaq
- Market Cap
- CAC N/A
- CRMD 753.6M
- IPO Year
- CAC 1997
- CRMD 2010
- Fundamental
- Price
- CAC $45.25
- CRMD $10.15
- Analyst Decision
- CAC Hold
- CRMD Strong Buy
- Analyst Count
- CAC 3
- CRMD 6
- Target Price
- CAC $48.33
- CRMD $15.67
- AVG Volume (30 Days)
- CAC 87.0K
- CRMD 1.5M
- Earning Date
- CAC 01-28-2025
- CRMD 03-11-2025
- Dividend Yield
- CAC 3.74%
- CRMD N/A
- EPS Growth
- CAC 21.89
- CRMD N/A
- EPS
- CAC 3.62
- CRMD N/A
- Revenue
- CAC $177,396,000.00
- CRMD $12,262,234.00
- Revenue This Year
- CAC N/A
- CRMD N/A
- Revenue Next Year
- CAC $10.12
- CRMD $246.41
- P/E Ratio
- CAC $12.27
- CRMD N/A
- Revenue Growth
- CAC 10.05
- CRMD 41184.20
- 52 Week Low
- CAC $28.62
- CRMD $2.89
- 52 Week High
- CAC $50.07
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- CAC 51.55
- CRMD 40.80
- Support Level
- CAC $45.00
- CRMD $11.90
- Resistance Level
- CAC $46.49
- CRMD $12.67
- Average True Range (ATR)
- CAC 1.20
- CRMD 0.73
- MACD
- CAC 0.24
- CRMD -0.27
- Stochastic Oscillator
- CAC 48.77
- CRMD 2.12
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.